Synthomer (LSE:SYNT) Capex-to-Revenue : 0.06 (As of Dec. 2023)

View and export this data going back to 1971. Start your Free Trial

What is Synthomer Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Synthomer's Capital Expenditure for the six months ended in Dec. 2023 was £-50.10 Mil. Its Revenue for the six months ended in Dec. 2023 was £895.60 Mil.

Hence, Synthomer's Capex-to-Revenue for the six months ended in Dec. 2023 was 0.06.

Synthomer Capex-to-Revenue Historical Data

The historical data trend for Synthomer's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthomer Capex-to-Revenue Chart

Synthomer Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Capex-to-Revenue

Get a 7-Day Free Trial

0.05

0.03

0.04

Synthomer Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Capex-to-Revenue	Get a 7-Day Free Trial															0.06	0.03	0.05	0.03	0.06

Competitive Comparison of Synthomer's Capex-to-Revenue

For the Specialty Chemicals subindustry, Synthomer's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synthomer's Capex-to-Revenue Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Synthomer's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Synthomer's Capex-to-Revenue falls into.

Synthomer Capex-to-Revenue Calculation

Synthomer's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-84)	/	1970.9
	=	0.04

Synthomer's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-50.1)	/	895.6
	=	0.06

Synthomer (LSE:SYNT) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Synthomer Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Synthomer's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Synthomer (LSE:SYNT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Synthomer PLC (LSE:SYNT) » Definitions » Capex-to-Revenue

Comparable Companies

Traded in Other Exchanges

SYYYF:USA SYNTl:UK 7YC2:Germany

Address

45 Pall Mall, London, GBR, SW1Y 5JG

Website

https://www.synthomer.com

Synthomer PLC is a specialty chemicals company. It supplies a variety of chemicals including latex and adhesives, which are used in a wide range of markets such as construction, coatings, textiles, paper, and healthcare. The company's products include styrene-butadiene rubber, which is used to make coated paper, packaging, bindings for carpet, foam mattresses, pillows and shoes; and nitrile butadiene latex used to make medical gloves and catheters, among others. The company organizes itself into five segments: performance elastomers, functional solutions, industrial specialties, adhesive Technologies and acrylate monomers. A vast majority of the company's revenue is generated by the performance elastomers and functional solutions segments combined.